Position in VCYT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,111,397
+$1,361,750 QoQ
Shares Held
52,978
-2.5% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#104
of 365 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $76,192,428 across 12 Diagnostics & Research names. VCYT ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
2,364,282 | $31,681,378 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
43,719 | $9,915,032 | |
| 3 | CSTL |
Castle Biosciences Inc
|
348,371 | $8,308,648 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
13,440 | $6,738,278 | |
| 5 | A |
Agilent Technologies, Inc.
|
43,014 | $5,713,549 | |
| 6 | ICLR |
Icon PLC
|
19,993 | $3,472,984 | |
| 7 | VCYT |
Veracyte, Inc.
This page
|
52,978 | $3,111,397 | |
| 8 | DHR |
Danaher Corp /De/
|
14,347 | $2,732,816 |
All Filings in VCYT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,111,397 | 52,978 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,749,647 | 54,320 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||